Gilman Hill Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026Gilman Hill Asset Management, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $56.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$56.4M
| Company | Shares | Value |
|---|---|---|
| BMYBRISTOL MYERS SQUIBB CO | 230,039 | $14.0M |
| PFEPFIZER INC | 414,018 | $11.6M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 121,175 | $6.7M |
| REGNREGENERON PHARMACEUTICALS, INC. | 6,200 | $4.8M |
| JNJJOHNSON & JOHNSON | 16,207 | $4.0M |
| ZBHZimmer Biomet Holdings Inc. | 39,014 | $3.5M |
| SUNSUNSET ISLAND GROUP | 48,559 | $3.2M |
| ABBVAbbVie Inc. | 14,404 | $3.1M |
| LLYELI LILLY & Co | 1,588 | $1.5M |
| MRKMerck & Co., Inc. | 10,857 | $1.3M |
| ABTABBOTT LABORATORIES | 9,850 | $1.0M |
| MCKMcKesson Corporation | 610 | $528K |
| IDXXIDEXX LABORATORIES INC /DE | 632 | $355K |
| AMGNAMGEN INC | 846 | $298K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 650 | $290K |
| GMOptec International, Inc. | 3,021 | $225K |
| OGNOrganon & Co. | 21,740 | $130K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.